[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.130.145. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 1,692
Citations 0
Correction
January 5, 2016

Incorrect Data in Tables and eFigure

JAMA. 2016;315(1):90. doi:10.1001/jama.2015.17311

In the Original Investigation entitled “Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial” published in the August 18, 2015, issue of JAMA,1 data were incorrect in the Tables and in the online eFigure 3. In Table 2, in the observed means row, the values shown in the Liraglutide columns (reported as −6.2, −4.8, −2.2) should have been reported as −5.9, −4.6, and −2.0, respectively; in addition, footnote “c” should have read “Number of participants not estimated.” In Table 3, in the “Increase” row in the “Change in net use of concomitant oral hypoglycemic agents” section, the first value in the Placebo column, reported as 7, should have been reported as 57. In panel “C” of eFigure 3 in the online Supplement, the value for placebo in the systolic blood pressure plot, reported as 1.2, should have been reported as 1.1. This article was corrected online.

References
1.
Davies  MJ, Bergenstal  R, Bode  B,  et al; NN8022-1922 Study Group.  Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE Diabetes randomized clinical trial. JAMA. 2015;314(7):687-699.
PubMedArticle
×